You searched for "chemotherapy"
Elevated prevalence of late-onset dysphagia among head and neck cancer survivors and identifying risk factors
Dysphagia is one of the most common problems affecting head and neck cancer (HNC) survivors. There are few studies investigating late-onset dysphagia post-treatment. The authors set out to investigate the prevalence of dysphagia-related diagnoses and procedures five years’ post-treatment, changes...
Predicting the prognosis of oral squamous cell carcinoma after salvage surgery
Loco-regional recurrence of oral cavity squamous cell carcinoma (OCSCC) continues to be a life-threatening and difficult clinical situation. Salvage surgery can result in significant morbidities, and survival following recurrence is generally poor. In this study from Ontario, Canada, prognostic factors...
External auditory canal carcinoma
Although uncommon, primary malignant tumours of the external auditory canal (EAC) are associated with a poor prognosis as they often present late. In this study the authors evaluate the clinical and pathological factors associated with treatment and outcome of EAC...From the editor March/April 2023
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk The world of audiology and ENT will already know of the tragic death of Professor David Baguley in June 2022 at...4th Annual Inner Ear Disorders Therapeutics Summit
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...
Sublingual immunotherapy
This paper reviews the recent European studies on sublingual immunotherapy (SLIT). SLIT is currently widely used in Europe and is gaining popularity in the United States. It is known that longer treatment is needed with SLIT compared with subcutaneous immunotherapy...Preventing avoidable deafness and death from ear disease in Ethiopia
In the July/August edition of the magazine, we featured an article on humanitarian work in Ethiopia, focusing on head and neck surgery. Continuing this theme, Misha Verkerk tells us about an international collaboration providing otology care and training in that...
Immunotherapy – could it be cheaper?
Immunotherapy is the only treatment for allergy to alter the disease course. Limited data exist on direct and indirect costs of subcutaneous (SCIT) and sublingual (SLIT) immunotherapy in America. This article assesses the cost effectiveness worldwide of the two immunotherapies....
Perioperative management of the head and neck cancer patient
The perioperative care of patients with head and neck cancer is complex and requires significant preoperative planning and patient education. The issues include analgesia, antibiotics, stoma and wound care, general and chest physiotherapy, thromboprophylaxis and nutrition. This article provides a...
Above and beyond interprofessional learning
There has been a significant focus on interprofessional education for all health professionals over recent years. The American Speech-Language-Hearing Association became a member of the Interprofessional Education Collaborative (IPEC) competencies (in America) in 2016. These competencies provide four core competencies...
Occupational hazards affecting otolaryngologists
This is a questionnaire survey which received responses from 323 clinicians practising otolaryngology. The grades ranged from consultants to junior doctors. It was noted that nearly half of these respondents suffered from some form of musculoskeletal pain and it highlights...
